Edition:
United States

Ben Hirschler

Jeff Mason is a White House Correspondent for Reuters and the 2016-2017 president of the White House Correspondents’ Association. He was the lead Reuters correspondent for President Barack Obama's 2012 campaign and interviewed the president at the White House in 2015. Jeff has been based in Washington since 2008, when he covered the historic race between Obama, Hillary Clinton and John McCain. Jeff started his career in Frankfurt, Germany, where he covered the airline industry before moving to Brussels, Belgium, where he covered the European Union. He is a Colorado native, proud graduate of Northwestern University and former Fulbright scholar.

Twitter handle: @jeffmason1

Jun 22 2017

Novartis heart drug success opens up new care option

ZURICH/LONDON A Novartis anti-inflammatory drug cut cardiovascular risk for heart attack survivors in a pivotal trial, potentially changing ideas about treatment.

Jun 21 2017

Shire wins U.S. approval for long-acting ADHD drug

Shire has won U.S. approval for a long-acting attention deficit drug aimed at adolescents and adults, boosting its stock of medicines for the cognitive condition that affects millions of children and is being diagnosed more in older people.

Jun 19 2017

GSK's new pharma head to join in September after AstraZeneca tussle

LONDON GlaxoSmithKline has struck a deal for Luke Miels to start as its new head of pharmaceuticals in September, following a lengthy dispute over his contract with his former employer AstraZeneca.

Jun 15 2017

UK will pay for Roche breast cancer drug at center of price row

LONDON A Roche breast cancer drug at the center of a prolonged pricing row in Britain will now be paid for routinely, following a discount deal between the company and the National Health Service (NHS).

Jun 15 2017

Google bets on European biotech drugs, backs new fund

LONDON Google is betting on the potential of European biotech companies to deliver life-changing drugs by investing alongside Swiss company Novartis in a new $300 million fund run by leading life sciences investment firm Medicxi.

Jun 13 2017

Aspirin linked to higher risk of serious bleeding in the elderly

LONDON People who are aged 75 or older and take aspirin daily to ward off heart attacks face a significantly elevated risk of serious or even fatal bleeding and should be given heartburn drugs to minimize the danger, a 10-year study has found.

Jun 12 2017

Flannery wins top GE job after nursing growth at healthcare unit

When John Flannery was chosen to head GE Healthcare in 2014, his background as chief dealmaker for the industrial conglomerate led to speculation GE might consider spinning off its somewhat sickly health business.

Jun 12 2017

Flannery wins top GE job after nursing growth at healthcare unit

When John Flannery was chosen to head GE Healthcare in 2014, his background as chief dealmaker for the industrial conglomerate led to speculation GE might consider spinning off its somewhat sickly health business.

Jun 12 2017

Flannery wins top GE job after nursing growth at healthcare unit

June 12 When John Flannery was chosen to head GE Healthcare in 2014, his background as chief dealmaker for the industrial conglomerate led to speculation GE might consider spinning off its somewhat sickly health business.

May 31 2017

Gilead and GSK go head-to-head with similar HIV drug data

(This story corrects story published on May 30 to show that two, not three, of the studies had enrolled previously untreated patients, in third and fourth paragraphs from the bottom.)

More From Around the Web

Markets

  • U.S.
  • Europe
  • Asia
  • Sectors

Sector Summary